Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of hypothermia on the disposition of morphine, fentanyl, midazolam and propofol in ICU patients
2006-001814-34Phase 4Completed
- Sponsor
- NTNU
- Start
- Jul 2006
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of morphine, fentanyl, midazolam and propofol in critical illness, Postischemic encephalopathy and post-cardiac arrest syndrome (PCAS) (2 arms), sponsored by NTNU. Primary endpoint: Terminal elimination half-life of morphine. Started Jul 2006; status: completed.
02
Drugs
morphinefentanylmidazolampropofol
03
Conditions
critical illnessPostischemic encephalopathypost-cardiac arrest syndrome (PCAS)
Beyond the preview
Go deeper on 2006-001814-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001814-34.